Atropos Health has been named to the CB Insights seventh annual “Digital Health 50” list, which showcases the 50 most promising private digital health companies globally. The company, which pioneers translating real-world clinical data into personalized evidence, was recognized for its achievements in real-world evidence (RWE) generation. The winners were selected by CB Insights based on criteria including deal activity, team strength, and proprietary scores.
Atropos Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
